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Prorein-tyrosine phosphorylation and dcphosphorylntion are directly associated with cellular growlh. signal transduction, and ncoplastic trnnsfor- 
mation. Here we report the isolation of a complementary DNA @DNA) clone encoding a novel protein-tyrosinc phosphatasc (PTP) from a human 
T cell PEER cDNA library. The predicted open reading frame encodes a -68.kDa protein composed of 593 amino acids which contains LWO 
src-homology region 2’s (SH2 domains) at the N terminus; this PTP is dcsibflated as SH-PTP3. Northern blot analysis revealed that SH-PTP3 
mRNA was expressed throughout many tissues and the transcriptional size wns consistent al about 6.0 kb. As with olhcr SH2 domains in x-family 
kinascs, the SH2 domains of SH-PTP3 may play a crucial role in interactions with tyrosinc phosphorylnlcd signding proteins, including itself and 
protein tyrosine kinascs (PTKs), to regulute targets’ enzyme activity. 
Protein-tyrosine phosphatasc; Protein lyrosine kinase; src-Homology region 2 
1. INTRODUCTION 
A variety of growth factors can lead protein tyrosine 
phosphorylation through receptor-linked protein-tyro- 
sine kinases (PTK) or their associated PTKs [1,23. The 
signals are mostly initiated by autophosphorylation of 
the receptors [3] and subsequently transduced via intra- 
cellular signaling pathways. In these signalings, SOL’ ho- 
mology region 2 (SH2) has a key role in the signaling 
process because tyrosine autophosphorylation of the 
receptors result in binding sites for prot.eins with SH2 
regions [4], for example, phospholipase C-y (PLC-y), 
and GTPase-activating protein (GAP) [5,6]. 
mains has been identified and dem.onstrated to form 
high-affinity complexes with the tyrosinephos- 
phorylated epidermal growth factor receptor [9]. Al- 
though the biological functions of SH-PTPl remain to 
be elucidated, the PTP may directly participate in signal 
transduction pathways. 
During signal transduction, phosphorylated tyro- 
sines within the regulatory domains in src-family ki- 
nases can be specifically dephosphorylated with corre- 
sponding protein-tyrosine phosphatascs (PTP) so as, 
ultimately, to increase signal transduction; this has been 
demonstrated for interactions between CD45 and pS6”” 
[7] or pS@“’ [S]. Thus, cross-talk among PTKs and PTPs 
is likely to have a crucial role in the control of cellular 
growth and differentiation. Recently, a PTP (PTPlC [9], 
SH-PTPl [lo] or HCP [ll]) which contains SH2 do- 
We have previously identified several PTPs expressed 
in pre-B cell NALM-6 by the reverse transcriptase- 
polymerase chain reaction (RT-PCR) technique [12], 
and have characterized a non-transmembrane PTP 
gene, LC-PTP [ 133 or HePTP [14], by the USC of the PCR 
cDNA probe (BPTP4) [12]. Here, we report the full- 
length cDNA sequence of another novel non-trans- 
membrane PTP (SH-PTPS), which has been cloned 
using another cDNA probe (BPTP-3) [12]. SH-PTP3 
possesses two SH2 domains at the amino (N)-terminus 
and shows a strong homology with SH-PTPl, but a 
fairly different nucleotide sequence. Thus, our data pro- 
vide another SHZ-encoding PTP, supporting the earlier 
suggestion of complicated cross-talk between PTKs and 
PTPS. 
2. MATERIALS AND METHODS 
Correspondencr oddress: M. Adachi, Department of Internal Medi- 
cine (Section I), Sapporo Medical College, S-l,W-16, Chuo-ku, Snp- 
poro, 060, Japan. Fax: (81) (I I) 613 1141. 
2.1. Isolctrion f LC-PTP cDNA rtotws 
Abbrevicrtions: PTP, protein-tyrosine phosphatasc; PTK, protein tyro- 
sine kinase; PCR, polymerasc hain reaction; cDNA, complementary 
DNA. 
*The sequence reported in this paper hnve been deposited in the 
EMBUCienBank data base under the accession umber D13540, 
A PEER cDNA library (Clontcch) was probed with a 0.26-kb 
BPTP-3 PCR product which had been isolated from total RNA of 
NALM-6 cells by RT-PCR [12]. Approximately 1.2 million plaques 
were transferred to nitrocellulox filters (Millipore) and screened. The 
hybridizztion condilions were 50% formamide/ x SSC (1 x SSC is 150 
mM NaCUl5 mM trisodium citrateyZ.5 x Denhnrdt’s olution, 0.1% 
SDS, 2.58 dcxirurl suifaie. and dcGaiu& c~!f &ym~ ONA f!OO 
pg/ml). The filtca were washed with 2 x SSC at 50°C and exposed to 
Amersham hyperfilms using an inlcnsifying screen. Hybridizing 
hrblir4ed by Elsevler Science Publishers R. K 335 
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Fig. I 
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Nucleotide and predicted amino acid sequence of the SH-PTP3 cDNA clone. The two SW2 domains are underlined, and a single PTP domain 
is indicated by brackets. Asterisks denote the stop codon. The single-letter amino acid code is used, 
phages were purified, and the phage DNAs were prepared and sub- 
cloned into the pBlueScript SK(-) plasmid (Strztzgcne) using 
siandard techniques. 
Closed circular plnsmid DNA was purified by CsCl density ccntrif- 
ugntion. For the sequcncingof both strands, WC generated overlapping 
deletion subclones of the longest SH-PTP3 cDNA clone with exonu- 
clease I11 and Mung Bean Nucleasc (Takara). The double stranded 
DNA was denatured with Q2 M NaOH and the DNA sequence was 
determined by the dideoxynucleotidc chain-tcrminntion procedure 
using either the manufacturer’s primers or synthetic oligonucleotidcs 
derived from the existing sequences. 
2.3. RNA bolarlott cm1 h’orrhcrrr blot analysis 
Total RNAs were extracted from human T cell leukemia lines 
(CEM, Jurkat, TALL-I, PEER), I3 cell malignant cells (BALL-I, 
RPM18226, NALM-B), mycloid cell lines (HL60), glioblastoma (A- 
172, T!XG), malignant mclonoma (Mcwo), fibroblast (WI-38). and 
colon carcinoma cells (BM314, COLD 201, CHC-YI) by the gun- 
nidium/CsCl procedure. WC also obtained total RNAs from various 
tissues of a patient under autopsy for cardiac failure (about 3 h after 
death). Ten micrograms of the total RNAs wcrc separated in 1% 
agarose formaldehyde gels by electrophoresis and were transferred to 
nitrocellulose iilters. The fillers were hybridized with 3Wl~~beled ran- 
dom primed cDNA lirngments as probes. The probe for the SH-PTP3 
gene was the 0.3-kb DNA fragment within the catalytic domain of the 
SH-PTP3 cDNA clone isolated from pm-B cell NALM-6 by RT-PCR 
[12]. The probe for /3-aclin was lhe 0.3-kb &unHl-&/I cDNA frag- 
ment of the PCR products, which wns confirmed by sequencing and 
was used as control. The hybridization and wash conditions were the 
same as described for cDNA isolation. The same blots were used LO 
test the SH-P?‘P3 and ,&acGn transcripts under identical conditions. 
2.4. Soutitcrtt blot uttulysis of SH-PTP2 
Human gcnomic DNA was exlractcd from human T cell leukemia 
336 
cells MOLT-3 and clezvcd with the restriction endonuclenses hrrtH1, 
&oRI ai;?. _V!zdf:i. The blol was hybridized wiih the “P-labeled 
cDNA 0.3-kb probe (PCR cDNA fragment). Hybridization and wash 
conditions were the same as those dcscribLxl for the screening of the 
library. 
3. RESULTS 
3.1. Isolation oJc SH-PTP2 cDN.4 chnes 
The 274 bp PCR cDNA fragment (BPTP-3) was used 
to isolate three cDNA clones from a human T cell leuke- 
mia PEER cDNA library. The sequence analysis of the 
longest cDNA fragment showed that this clone con- 
tained a single open reading frame (ORF) of 1,779 bps 
encoding a polypeptide of 593 amino acids and a 3’ 
untranslated region (Fig. I). The nucleotides located at 
positions 154 to 160 around the first available ATG/ 
methionine match well with the Kozac consensus se- 
quence for eukaryotic translation initiation [ 151. There 
is an upstream termination codon TGA at position 112 
in this frame. The ORF encodes a protein of approxi- 
mately 68 kDa and terminates with a TGA stop codon 
at position 1,936. SW-PTP3 lacks a signal sequence or 
potential transmembrane r gion, indicating SH-PTP3 is 
a non-transmembrane PTP. The carboxyl region, 
amino acids (a.a.) 202 to 455, contains a single catalytic 
domain of PTP molecules with the highly conserved 
consensus equence HCSAGlGR, which is commonly 
seen in non-transmembrane PTPs [13]. SH-PTP3 is 
most closely related to CD45 [ 161 and HPTPoc [17] 
(these PTPs are 38.6% identical over 324 a.a.). The most 
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Fig. 2. RNA transfer blot analysis of SH-PTP3 tmnscript. (A) Totnl RNA samples wcrcextractcd from human Tccll leukemia lines (CEM, Jurkat, 
TALL-l, PEER), B cell malignant cells (BALL-I, RPM1822G, NALM-6). myeloid cell lines (HL60). glioblastomn (A-172, T98Ci), matignant 
melanoma (Mewo), pulmonary fibroblast (W-38), and colon carcinoma cells (BM314, COLO 201. CHC-YI), nnd (B) from human tissues from 
an autopsy subject. Ten ,ug of total RNAs wcrc clcctrophorcsed (1% agarosc gel), transferred to nitroccllulosc filters, arld hybridized with the 
. ‘“P-labcllcd SH-PTP3 cDNA probe. After the first autoradiography, the same filters were rchybridized with “P-lnbclcd ,!?-nctin cDNA probe to 
confirm equal loading (bottom). The positions of ribosomal RNA markers arc indicated to the lcfi of the blots. 
striking feature of SH-PTP3 is that this contains two 
SH2 domains at the N-terminus (Fig. 1). It is notewor- 
thy th.at he SH2 domains contain the invariant residues 
found in SM2 domains of other molecules PTK, PLC-1, 
and GAP. In addition, there are two FLVRESES motifs 
which have been suggested to be involved in phosphoty- 
rosine binding [18], FLVRESQS (a.a. 135 to 142) and 
FLARPSKS (a.a. 25, to 36) segments (Fig. 1). Interest- 
i@y, carboxyl (C) terminus contains nuclear localiza- 
tion-like motif [19], KRKRK (a.a. 534 to 538) and the 
prolin-rich domain (a.a. 55 1 to 568). Furthermore, there 
is a consensus sequence for ATP binding site 
(GXXXXGKS) [20] within the N-terminal SH2 domain 
( a.a. 158 to 165). 
3.2. Broad expressiorz of SWPTP3 r.rutmrip’prs 
Northern blot analysis of SW-PTP3 mRNA revealed 
approximately B.O-kb transcripts. Initial studies of some 
cell lines showed SH-PTP3 transcripts in all the lines 
examined. A wide variety of cell lines and human tissues 
were then analyzed; SH-PTP3 was found in every kind 
of tissue we examined, though at considerably differing 
337 
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Fig. 3. Southern blot analysis of SH-PTP3. Ten yg of genomic DNA 
from MOLT-3 was digested with the indica& restriction enzymes, 
clcctrophoresed (0.7% agarose gel), transferred to nitrocelluloss fil- 
ters, and hybridized with the “P-lab&d SH-PTP3 cDNA probe. 
Mobility of DNA standards (kb) is shown at left. 
levels of expression (Fig. 2). It was present at somewhat 
high levels in our one sample of brain tissue (Fig. 2B). 
3.3. Southern blot analysis of SKPTP.3 
Southern blot of human genomic DNA was hybrid- 
ized with SH-PTP3 cDNA probe containing the cata- 
lytic domain. The blots revealed several bands of hy- 
bridization (Fig. 3), indicating that either the gene is 
huge with many introns or that there are multiple genes 
for SH-PTPs. Since the Northern blot analysis revealed 
a single transcript (-6.0 kb), it is likely that the SH- 
PTP3 gene is very large and consists of complicated 
exon-intron organizations. These multiple bands con- 
stantly appeared in at Least hree independent experi- 
ments with high stringency (data not shown). 
4. DISCUSSION 
We have isolated a novel non-transmembrane PTP 
(SH-PTP3) with two SH2 domains from a human T cell 
leukemia cell PEER cDNA library. Recently, a PTP 
with two SH2 domains has been identified in many 
laboratories [g-11]; it has been dubbed with a corre- 
spondingly wide variety of names, but because of some 
striking features of its structure and preliminary data 
suggesting additional SHZ-encoding PTPs, the name 
SH-PTPl [lo] is used in this presentation. Overall, our 
novel SH-PTP3 is highly homologous to the SH-PTPi 
(7 I8 idefititr;, Nu”l*.4:& -ACYCIYC S~~Z%EX Si*Kii!Zi?~* in ths 
coding regions is not so high (39.6% identity), which 
appears to have been the reason we could not detect 
transcripts of SH-PTPl (2.6 kb) with SM-PTP3 probes 
338 
Fig. 4. Amino acid sequence omparison between SW-PTP3 (rat and 
human) and SH-PTPl. Two FLVRESES motifs were shown by bold- 
face type. Amino acid sequence availnblc for rat SH-PTP3 (Ll) is 
ovcrlined and the arginine (R) indicates an amino acid which is differ- 
cnt from human SII-PTP3 sequence, The putative ATP binding do- 
main is ovcrlincd with a broken line and the consensus cqucnce for 
nuclear localization signal is double overlined. The proline-rich do- 
main is indicated by asterisks. Gaps (space) were introduced to opti- 
mize alignments. 
under our conditions. Interestingly, SH-PTP3 is ex- 
pressed throughout many tissues (Fig. 2), whereas SH- 
PTPl is predorninantly expressed in hematopoietic ells 
[l 11. These different expression patterns may be associ- 
ated with their biological functions. 
The evidence summarized above conclusively demon- 
strates, we believe, that there is a subfamily of PTPs 
with SH2 domains. SH2 domains contain approxi- 
mately 100 amino acids that are highly conserved 
among the SK family members, and recently have also 
been found in cytoplasmic signaling proteins including 
PLC-I)I, GAP, an 85-kDa subunit of PI3’-kinase [21], 
and the v-c& oncogene [22]. The roles of the SH2 do- 
mains of these signaling proteins suggest several possi- 
ble functions for the SH2 domains in SH-PTP3. First, 
as the SH2 domains of src-like kinases [23], !?&I2 do- 
mains of SM-PTP3 may interact with its own tyrosine 
phosphorylation sites to negatively regulate enzyme ac- 
tivity. It is necessary to investigate whether SH-PTP3 
itself can be tyrosine phosphorylated. Second, SH2 do- 
mains directly interact with signaling proteins and the 
resultant complexes may activate them or make them 
accessible to specific substrates by tyrosine dephos- 
phorylation. Third, SH2 domains can target activated 
s:g.?a!ing proteins for s:,,,~,l +ti~m:n~t:nn h,, MWW-~;~~ rg..bb. .“.I.....H..Y.. Y, .“I”. . . 0 
tyrosine phosphorylation. 
Recently, PTP Ll has been purified from rat liver 
cytosol; the amino acid sequence of the peptides indi- 
Volume 314, number 3 FEBS LETTERS Deccrnber 1992 
cates that PTP LI [24] has extensive similarity (only one 
a.a. difference within the available sequence) to SH- 
PTP3 (Fig. 4)), implying that they are species homologs. 
The molecular mass of purified Ll is estimated to be 67 
kDa by SDS-PAGE 1241, which is similar to the molec- 
ular weight (68 kDa) of the predicted protein for SH- 
PTP3. Interestingly, Ll preferentially dephosphorylates 
tubulin [24], suggesting Ll (SH-PTP3) can be associated 
with microtubule-based motility. In view of the nucleo- 
tide-dependent interaction of SH-PTP3 with microtu- 
bules, it is of interest that SH-PTP3 possesses the con- 
sensus sequence for ATP binding, GXXXXGKS [20], 
which is found in SH-PTP3 sequence beginning at 
Gly’? 
Interestingly, SH-PTP3 has a nuclear localization sip 
nal-like segment. So far two PTKs (c-c&f and c-fir) have 
been localized to the nucleus [25,26]. Their biological 
functions are being studied extensively, but are still ob- 
scure. Recently, loss of phosphotyrosine in ~34~‘~ was 
shown to be associated with activation of intrinsic serine 
kinasc activity and appears to be a necessary step in the 
G2 to M transition in, cell cycle [27]. Importantly, 
P35 cdc2s has been demonstrated to manifest intrinsic 
PTP activity; it dephosphorylates the phosphotyrosine 
of ~34~” 1281. Thus, the enzyme activity of some aerine/ 
threonine kinases is also likely to be regulated by their 
own tyrosine-phosphorylation and dephosphorylation, 
suggesting important roles of SH2 domains. SH-PTP3 
is ubiquitously expressed in human tissues and pos- 
sesses a nuclear localization signal. These data suggest 
the attractive prospect hat SH-PTP3 can participate in 
the modification of phosphotyrosine, a crucial step in 
the cell cycle. 
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